A Study to Evaluate Pegsitacianine, an Intraoperative Fluorescence Imaging Agent for the Detection of Peritoneal Metastases in Patients Undergoing Cytoreductive Surgery

This study involves metastatic, stage 4 cancer, that has spread to your abdominal cavity and your cancer surgeon recommends surgery to remove cancer tumors from your abdomen. The purpose of this research study is to learn if the investigational study drug, pegsitacianine, helps in seeing the metastatic cancer disease left behind following the standard of care cancer surgery to remove the metastatic tumors. This study will also help to learn about the safety of the study drug and the ability to see the metastatic cancer tumors of each person in the study.

You may be eligible for this study if you meet the following criteria:

• Conditions:
  Peritoneal Carcinomatosis
• Age: Between 18 Years - 99 Years
• Gender: All